Who we are.

Join the fight against pancreatic cancer! The 2015 Pancreatic Cancer Research Walk is Sunday, November 1st at Sloan's Lake Park, Denver, CO.

All the money raised goes directly to pancreatic cancer research thanks to the Lustgarten Foundation!

Thursday, February 20, 2014

Nuvilex's Pancreatic Cancer Treatment Readies to Challenge Eli Lilly and Celgene in Late-Phase ...

Nuvilex's Pancreatic Cancer Treatment Readies to Challenge Eli Lilly and Celgene in Late-Phase ...
NEW YORK, NY--(Marketwired - Feb 19, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a small biotech firm in Silver Spring, Maryland, that hopes to soon be ...
Google Plus Facebook Twitter Flag as irrelevant
Biotech/Pharma Companies Targeting Pancreatic Cancer: (SBFM), (NLNK), (LLY), (CELG)
Point Roberts WA, New York, NY - February 19, 2014 (Investorideas.com Biotech Newswire) Investorideas.com global news source covering leading ...
Google Plus Facebook Twitter Flag as irrelevant
Family researching possible cancer cluster hears from officials - KATV - Breaking News, Weather ...
Just with their research, the women have found 9 pancreatic cancer cases in a mile radius. Since Channel Seven aired the story, the total is 18.
Google Plus Facebook Twitter Flag as irrelevant
Letter: Help fight cancer
Specifically, pancreatic cancer has consumed and destroyed many lives, and the Pancreatic Cancer Action Network Baton Rouge does not want ...
Google Plus Facebook Twitter Flag as irrelevant
Trib- Today
Patricia A. Smolinsky 1949-2014
The family suggests that memorial contributions take the form of donations in Ms. Smolinsky's name to the Pancreatic Cancer Action Network, 1500 ...
Google Plus Facebook Twitter Flag as irrelevant
Community advocate and Aveda founder Horst Rechelbacher dead at 72
Horst Rechelbacher, the founder of Aveda and Intelligent Nutrients, passed away at the age of 72 on Feb. 15 following a battle with pancreatic cancer.
Google Plus Facebook Twitter Flag as irrelevant
RedPath Sponsors Scientific Presentation at 37th NYSGE Annual New York Course
... 492 patient outcomes showed that integrated molecular pathology correctly identifies those patients at very low risk of developing pancreatic cancer.
Google Plus Facebook Twitter Flag as irrelevant
Andrew 'Andy' Johnson
... on Saturday, February 15, 2014, at the Midwestern Regional Medical, Cancer Treatment Center in Zion, Ill., following a battle with pancreatic cancer.

No comments:

Post a Comment